Skip to main content
Top
Published in: Reactions Weekly 1/2012

01-03-2012 | Case report

Paliperidone

First report of anaphylactoid reaction: case report

Published in: Reactions Weekly | Issue 1/2012

Login to get access

Excerpt

An event is serious (FDA MedWatch definition) when the patient outcome is:
  • death
  • life-threatening
  • hospitalisation
  • disability
  • congenital anomaly
  • requires intervention to prevent permanent impairment or damage
Literature
1.
go back to reference Perry R, Wolberg J, DiCrescento S.Anaphylactoid reaction to paliperidone palmitate extended-release injectable suspension in a patient tolerant of oral risperidone. American Journal of Health-System Pharmacy 69: 40-43, No. 1, 1 Jan 2012. Available from: URL: http://dx.doi.org/10.2146/ajhp110230 - USA Perry R, Wolberg J, DiCrescento S.Anaphylactoid reaction to paliperidone palmitate extended-release injectable suspension in a patient tolerant of oral risperidone. American Journal of Health-System Pharmacy 69: 40-43, No. 1, 1 Jan 2012. Available from: URL: http://​dx.​doi.​org/​10.​2146/​ajhp110230 - USA
Metadata
Title
Paliperidone
First report of anaphylactoid reaction: case report
Publication date
01-03-2012
Publisher
Springer International Publishing
Published in
Reactions Weekly / Issue 1/2012
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI
https://doi.org/10.2165/00128415-201213920-00124

Other articles of this Issue 1/2012

Reactions Weekly 1/2012 Go to the issue

Case report

Tolvaptan

Case report

Paclitaxel

Case report

Rituximab

Case report

Ceftriaxone

Case report

Thiamazole